#BIO2011: Meeeeemories Light the Corners of My Mind
OK, I officially promise never to quote Barbra’s songs again . . .but, with the 2011 BIO International Convention just a mere three weeks ago – it seems like a distant memory for some of us and a blur for…
A Tale of Two Conferences: ASCO and BIO
The American Society of Clinical Oncology (ASCO) Annual Meeting kicked off the month of June as, arguably, the biggest event in the life sciences milieu, with 30,000-plus attendees and an inconsistent mélange of dispiriting and heartening news and data, while…
In the Eye of the Beholder
Placebos clearly have an effect on patient’s subjective feelings of illness. Many a rueful drug developer, especially of antidepressants, can attest to that. But whether they have a physical effect has not been studied. Researchers at Beth Israel Deaconess Medical…
Putting Overseas Earnings to Work
It doesn’t take a PhD in economics to come up with practical solutions to jumpstart our economy and create jobs. But it does take guts – and real-world vision – to implement change that makes a difference.
First-Half Biotech Fundraising: What You Need to Know
We just finished running the numbers for biotech fundraising in the first half of 2011, and . . . drum roll please . . . the numbers are good! Well, they’re good if you’re a publicly traded, pre-commercial biotech, anyway.
The HIV Cure and a Culture of Low Expectations
By Catherine Shaffer, BioWorld Today Contributing Writer
Four Days Later: The De-Evolution of a #2011BIO Attendee
By Jennifer Boggs, Assistant Managing Editor
Video Coverage from #BIO2011 – Exclusive Interview with CEO of Bio, Biotechnology Industry Organization
BioWorld interviews James C. Greenwood, President and Chief Executive Officer of Bio. Greenwood shares the legislative goals of the Biotechnology Industry Organization at the 2011 Bio International Convention on June 30, 2011 in Washington, DC.
#BIO 2011: Agony of De Feet
WASHINGTON ‑ If there’s any universal experience of the BIO International Conference, it has to be foot fatigue. You hear about it in snatches in the hallway. “My feet are aching.” “I have to get off my feet.” “My blisters…
Video Coverage from #BIO2011 – Exclusive Interview with AVANIR Pharmaceuticals
Today at the 2011 Bio International Convention, we had the opportunity to speak with Keith A. Katkin, President and Chief Executive Officer of Avanir Pharmaceuticals. Katkin discusses the recent FDA approval of Nuedexta for the treatment of pseudobulbar affect (PBA).
Join the Conversation